Patents by Inventor Arshed A. Quyyumi

Arshed A. Quyyumi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
    Patent number: 11079395
    Abstract: Provided herein are methods for predicting or determining whether a subject with coronary artery disease is likely to experience or develop a major adverse cardiovascular event (MACE) based on determining cardiac troponin (cTnI) levels in a human at rest and during or after exercise.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: August 3, 2021
    Assignees: Abbott Laboratories, Emory University
    Inventors: Agim Beshiri, Arshed A. Quyyumi
  • METHODS FOR PREDICTING MAJOR ADVERSE CARDIOVASCULAR EVENTS IN SUBJECTS WITH CORONARY ARTERY DISEASE
    Publication number: 20200278357
    Abstract: The present disclosure relates to methods for predicting or determining whether a subject with coronary artery disease is likely to experience or develop a major adverse cardiovascular event (MACE) based on comparing the concentration or levels of cardiac troponin I (cTnI) determined by one or more assays before a stress test and then during or after a stress test.
    Type: Application
    Filed: February 28, 2020
    Publication date: September 3, 2020
    Inventors: Agim Beshiri, Arshed A. Quyyumi
  • DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK
    Publication number: 20160146834
    Abstract: This invention relates to the area of cardiovascular disorders and specifically relates to methods of diagnostic tests using a combination of markers to predict an individual's risk for developing coronary artery disease (CAD) and related diseases, such as angina pectoris and peripheral vascular disease and, more particularly, to determine an individual's risk of myocardial infarction, death, and stroke. Exemplary biomarkers include C-reactive protein (CRP), fibrin degradation products (FDPs), Heat Shock Protein 70 (HSP70), urokinase or urokinase receptor (uPA/uPAR), and/or anti-CMV antibody.
    Type: Application
    Filed: July 11, 2014
    Publication date: May 26, 2016
    Applicant: Emory University
    Inventor: Arshed A. QUYYUMI
  • DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK
    Publication number: 20140350129
    Abstract: This invention relates to the area of cardiovascular disorders and specifically relates to methods of diagnostic tests using a combination of markers to predict an individual's risk for developing coronary artery disease (CAD) and related diseases, such as angina pectoris and peripheral vascular disease and, more particularly, to determine an individual's risk of myocardial infarction, death, and stroke. Exemplary biomarkers include C-reactive protein (CRP), fibrin degradation products (FDPs), Heat Shock Protein 70 (HSP70), and/or anti-CMV antibody.
    Type: Application
    Filed: March 1, 2012
    Publication date: November 27, 2014
    Applicants: Genway Biotech, Inc., Emory University, Medstar Health Research Institute
    Inventors: Sergey Sikora, Stephen Epstein, Arshed A. Quyyumi
  • Method for diagnosis and treatment of vascular disease
    Patent number: 7708977
    Abstract: A method for diagnosing decreased vascular function is disclosed. The method includes assaying the number of endothelial progenitor cells. A method for detecting increased cardiovascular risk is also disclosed, as is a method for diagnosing atherosclerosis. In one example, the methods include assaying the number of endothelial progenitor cells. A method for treating a subject with decreased vascular function is disclosed. The method includes administering a therapeutically effective amount of endothelial progenitor cells to the subject. In one embodiment, the subject has atherosclerosis.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: May 4, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Toren Finkel, Jonathan M. Hill, Arshed A. Quyyumi
  • Methods and compositions for treating diastolic dysfunction
    Publication number: 20080075666
    Abstract: Methods and compositions for treating and screening drugs for conditions are provided.
    Type: Application
    Filed: August 27, 2007
    Publication date: March 27, 2008
    Inventors: Samuel Dudley, Tai-Hwang Fan, David Harrison, Arshed Quyyumi
  • Method for diagnosis and treatment of vascular disease
    Publication number: 20060057072
    Abstract: A method for diagnosing decreased vascular function is disclosed. The method includes assaying the number of endothelial progenitor cells. A method for detecting increased cardiovascular risk is also disclosed, as is a method for diagnosing atherosclerosis. In one example, the methods include assaying the number of endothelial progenitor cells. A method for treating a subject with decreased vascular function is disclosed. The method includes administering a therapeutically effective amount of endothelial progenitor cells to the subject. In one embodiment, the subject has atherosclerosis.
    Type: Application
    Filed: November 12, 2003
    Publication date: March 16, 2006
    Inventors: Toren Finkel, Jonathan Hill, Arshed Quyyumi